OBJECTIVES: SNP rs2473277 upstream of the cell division cycle 42 (CDC42) gene was associated with schizophrenia in a recent genome-wide association study (GWAS). Reduced expression of CDC42 in schizophrenia has previously been reported. Our objective was to test whether the associated SNP affected CDC42 expression. METHODS: Two available SNP × gene expression datasets were accessed to test the effect of rs2473277 on CDC42 expression: (i) the mRNA by SNP Browser, which presents results of a genome-wide linkage study of gene expression, and (ii) the Genevar HapMap expression dataset. rs2473277 is in strong linkage disequilibrium (LD) with the SNP rs2473307 (r(2) =0.96), which is predicted to affect transcription factor binding. rs2473307 was directly tested for allelic effects on gene expression using a gene reporter assay in a human neuronal cell line. RESULTS: In both datasets, the schizophrenia risk allele at rs2473277 was associated with a reduction in CDC42 mRNA levels. In the reporter gene assay the risk allele at rs2473307 similarly reduced gene expression. CONCLUSIONS: We found evidence that rs2473307, in strong LD with the schizophrenia associated SNP rs2473277, is a functional variant at CDC42 that may increase risk for schizophrenia by reducing expression of CDC42.
OBJECTIVES: SNP rs2473277 upstream of the cell division cycle 42 (CDC42) gene was associated with schizophrenia in a recent genome-wide association study (GWAS). Reduced expression of CDC42 in schizophrenia has previously been reported. Our objective was to test whether the associated SNP affected CDC42 expression. METHODS: Two available SNP × gene expression datasets were accessed to test the effect of rs2473277 on CDC42 expression: (i) the mRNA by SNP Browser, which presents results of a genome-wide linkage study of gene expression, and (ii) the Genevar HapMap expression dataset. rs2473277 is in strong linkage disequilibrium (LD) with the SNP rs2473307 (r(2) =0.96), which is predicted to affect transcription factor binding. rs2473307 was directly tested for allelic effects on gene expression using a gene reporter assay in a human neuronal cell line. RESULTS: In both datasets, the schizophrenia risk allele at rs2473277 was associated with a reduction in CDC42 mRNA levels. In the reporter gene assay the risk allele at rs2473307 similarly reduced gene expression. CONCLUSIONS: We found evidence that rs2473307, in strong LD with the schizophrenia associated SNP rs2473277, is a functional variant at CDC42 that may increase risk for schizophrenia by reducing expression of CDC42.
Authors: Anita L Pinner; Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff Journal: Schizophr Res Date: 2016-02-11 Impact factor: 4.939
Authors: Eva Cristina de Oliveira Figueiredo; Bianca Maria Bondiolotti; Anthony Laugeray; Paola Bezzi Journal: Int J Mol Sci Date: 2022-04-16 Impact factor: 6.208
Authors: Jun Mukai; Makoto Tamura; Karine Fénelon; Andrew M Rosen; Timothy J Spellman; Rujun Kang; Amy B MacDermott; Maria Karayiorgou; Joshua A Gordon; Joseph A Gogos Journal: Neuron Date: 2015-04-23 Impact factor: 17.173
Authors: Sinead E Shortall; Ola H Negm; Maxine Fowler; Lucy C Fairclough; Patrick J Tighe; Peter M Wigmore; Madeleine V King Journal: Mol Neurobiol Date: 2018-02-08 Impact factor: 5.590
Authors: Kris A Christensen; Eric B Rondeau; Dionne Sakhrani; Carlo A Biagi; Hollie Johnson; Jay Joshi; Anne-Marie Flores; Sreeja Leelakumari; Richard Moore; Pawan K Pandoh; Ruth E Withler; Terry D Beacham; Rosalind A Leggatt; Carolyn M Tarpey; Lisa W Seeb; James E Seeb; Steven J M Jones; Robert H Devlin; Ben F Koop Journal: PLoS One Date: 2021-12-17 Impact factor: 3.240
Authors: Corneliu A Bodea; Adele A Mitchell; Alex Bloemendal; Aaron G Day-Williams; Heiko Runz; Shamil R Sunyaev Journal: Genome Biol Date: 2018-10-25 Impact factor: 13.583